Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4118 USD | -8.06% | -0.31% | -10.50% |
20/03 | UBS Adjusts Singular Genomics Systems Price Target to $0.50 From $0.40, Maintains Neutral Rating | MT |
18/03 | Transcript : Singular Genomics Systems, Inc., Q4 2023 Earnings Call, Mar 18, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.50% | 3.05Cr | |
+17.96% | 4.5TCr | |
+1.17% | 4.26TCr | |
+46.56% | 4.18TCr | |
-4.27% | 2.9TCr | |
+11.42% | 2.61TCr | |
-21.39% | 1.9TCr | |
+4.86% | 1.28TCr | |
+27.29% | 1.21TCr | |
-3.50% | 1.18TCr |
- Stock Market
- Equities
- OMIC Stock
- News Singular Genomics Systems, Inc.
- UBS Adjusts Singular Genomics Systems Price Target to $0.90 From $1, Maintains Neutral Rating